CJC1295 With DAC incorporates a Drug Affinity Complex enabling albumin association for extended stability in research settings. The peptide backbone retains motifs that influence secondary structure and receptor interaction. Researchers employ it to study peptide half-life modification strategies and conformational effects of macro-conjugation. Its engineered design supports advanced pharmacodynamic modeling.
CAT No: HB00124
CAS No:446262-90-4
Synonyms/Alias:CJC1295 Without DAC;CJC1295 With DAC;446262-90-4;L-Lysinamide,L-tyrosyl-D-alanyl-L-a-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-a-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More